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For over 30 years, the Center for Global Health and Prevention (CDC)  
has helped strengthen public health and laboratory systems in Kenya, creating an integrated and  
state-of-the-art research and program center. This model ties together multiple program areas, 
leveraging program strengths and working in partnership with the Government of Kenya to help 
build sustainable public health capacity. 
CDC Kenya saves lives by conducting research on the effectiveness of new interventions—such as 
vaccines, drugs, and diagnostics—and by implementing evidence-based public health programs to 
prevent disease and reduce death and disability.  As part of the Center for Global Health, CDC Kenya 
advances science and technology in Kenya and the East Africa region, particularly where current 
solutions are lacking. Once tools are shown to be effective, CDC Kenya evaluates ways to improve 
delivery and address obstacles to uptake. CDC Kenya helps translate research findings into policy 
recommendations alongside the Government of Kenya, World Health Organization, and other 
partners. CDC Kenya plays a key role in several global health initiatives, including the U.S. President’s 
Emergency Plan for AIDS Relief, the U.S. President’s Malaria Initiative and the Global Polio Eradication 
Initiative.  
Our Areas of Focus 
Developing Surveillance and Health Information Systems 
 Supporting the development and implementation of population and facility-based disease 
surveillance systems that provide for data collection, analysis, and reporting to assess disease  
burden in communities, identify outbreaks, and evaluate the impact of health interventions. 
 Spearheading state-of-the-art and mobile data collection systems. 
Building Public Health Workforce Capacity 
 Training future public health leaders in clinical, laboratory, public health science, program 
management, and leadership competencies. 
Strengthening Laboratory Systems 
 Building the critical laboratory network necessary to assure health security. 
Improving Emergency Preparedness & Response 
 Strengthening public health capacity to rapidly identify and contain infectious disease threats  
as well as respond to natural and man-made disasters. 
Conducting Research and Monitoring & Evaluation 
 Partnering with the Kenya Medical Research Institute (KEMRI), universities, and other 
stakeholders to provide an evidence base for interventions, like insecticide treated bed nets, 
used around the world. 
Implementing Evidence-based Public Health Programs 
 Evaluating, implementing, and scaling up proven approaches to achieve large-scale and 
demonstrable reductions in morbidity and mortality. 
Translating Research into Public Health Policy & Practice 
 Collaborating with partners in Kenya and globally to use evidence gained through research to 




CDC office (physical 
presence) 
172  U.S. Assignees and 
Locally Employed 
 
At a Glance  
Population: 44 million 
Per capita income: $1,700 
Life expectancy at birth 
women/men: 61 yrs 
Source: US Census Bureau, International 
Database, 2012 
CIA Factbook, 2012 
 
Top 10 Causes of Death 
1. HIV/AIDS 41% 
2. Cancer 8% 
3. Stroke 5% 
4. Diabetes 4% 
5. Tuberculosis 4% 
6. Interpersonal Violence 4% 
7. Diarrheal Diseases 4% 
8. Lower Respiratory 
Infections 3% 
9. Ischemic Heart Disease 3% 
10. Chronic Kidney Disease 
2% 
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Our Programs 
Global Health Protection supports efforts to protect the public’s health by developing and 
strengthening Kenya’s ability to rapidly detect and respond to disease outbreaks and 
emerging infectious diseases.  
 Refugee Health Program works with the United Nations High Commissioner for 
Refugees and other partners to reduce morbidity and mortality among refugees by 
responding to outbreaks and tracking health risks in East Africa. 
 International Emerging Infections Program provides technical assistance to 
governments in the East Africa region to ensure rapid, coordinated detection and 
response and promote comprehensive outbreak surveillance. 
 Influenza Program supports influenza surveillance to detect new influenza strains, 
monitor risk factors for severe disease associated with influenza virus infections, and 
to evaluate new diagnostic, treatment, and prevention strategies. 
 Diagnostics and Laboratory Systems Program helps Kenya develop enhanced  
state-of-the-art diagnostic capacity to process and test specimens in-country. 
 Field Epidemiology and Laboratory Training Program has graduated 100 future 
global health leaders with advanced skills in epidemiology and laboratory 
management. 
 Integrated Human-Animal Health Program promotes a “One Health” approach  
and involves human, animal, and environmental health experts to address epidemic 
threats of zoonotic origin. 
 Risk Communication and Emergency Response Program works with first 
responders, humanitarian organizations and Ministries of Health in the region 
providing technical support on emergency preparedness, response and recovery  
and risk communication. 
 Global Immunization Program works with international partners on improving 
immunization, particularly in polio outbreak response in Kenya and neighboring 
countries. 
 
U.S. President's Malaria Initiative provides technical assistance to design, implement  
and evaluate key malaria prevention and control activities in close coordination with the 
Government of Kenya and other partners. 
Global HIV/AIDS Program supports the Government of Kenya’s efforts to expand and 
strengthen national HIV prevention, care, treatment, and surveillance by providing technical 
and financial support through the U.S. President’s Emergency Relief Fund for AIDS (PEPFAR). 
 HIV Prevention develops guidance and supports best practices among partners who 
offer HIV testing and counseling; voluntary medical male circumcision,  
evidence-based behavioral interventions, and prevention programs for key 
populations at high risk for HIV. 
 HIV Care &Treatment helps thousands of Kenyans living with HIV to receive care and treatment, including services for pregnant 
women and mothers with HIV designed to reduce risk of mother-to-child transmission of the virus. 
 Health Systems and Evaluation strengthens health systems and promotes quality of data, programs and scientific 
dissemination to advance Kenya’s national HIV response. 
 Surveillance and Epidemiology provides expert guidance in implementing HIV surveillance and conducting public health 
research to improve programs and inform HIV policy. 
 Laboratory, Blood Safety & Infection Control focuses on improving the accessibility and quality of laboratory services and 
reducing the risk of HIV infection through improved blood safety and infection control practices in healthcare and laboratory 
facilities. 
Western Kenya Programs are implemented in close collaboration with KEMRI. This collaboration of more than 30 years has developed 
into a sophisticated and comprehensive platform for scientific study and service delivery.  
 HIV Research evaluates new tools to prevent the spread of the epidemic and improve the health of persons infected with HIV.  
 Tuberculosis Research measures the burden of TB and helps develop new ways to prevent and treat the disease. 
 Malaria Research conducts surveillance, and innovative research aimed at reducing morbidity, mortality and transmission.  
CDC supports important work including the Health and Demographic Surveillance System, which allows scientists to monitor the 
health and demographic information for over 225,000 people in Kibera, Nairobi and Lwak, Western Kenya. Surveillance data are 
used to inform policy and plan public health interventions. In addition, CDC supports research on Neglected Tropical Diseases. 
Impact in Kenya 
 3.4 million people received HIV 
counseling and testing results in 
2014 Of 6.5 million under PEPFAR 
Kenya 
 6.5 million Malaria rapid diagnostic 
tests and 4 million treatments for 
malaria procured and delivered by 
the President’s Malaria Initiative 
(PMI) in 2013 
 ISO 15189 laboratory accreditation 
obtained for CDC, KEMRI and 
National Public Health Laboratory 
(NPHL) microbiology laboratory 
activities 
 31,000 HIV-positive pregnant 
women received a full course of 
antiretroviral prophylaxis in 2014  
Of 57,000 under PEPFAR Kenya 
425,000 individuals received 
antiretroviral therapy, including 
40,000 children, in 2014 Of 740,000, 
including 71,000 children, under 
PEPFAR Kenya 
 154,000 voluntary medical male 
circumcisions to reduce HIV risk 
were performed in 2014 Of 229,000 
under PEPFAR Kenya 
 1,300 individuals are enrolled into 
two phase III malaria vaccine trials of 
one of the most promising vaccines 
 58,000 people participate in 
surveillance for respiratory, jaundice, 
febrile, and diarrheal conditions 
 225,000 people are part of a health 
and demographic surveillance 
system that collects health and 
demographic information every four 
months 
For more information please contact Centers for Disease Control and Prevention: 
CDC-Atlanta  
1600 Clifton Road NE, Atlanta, GA 30333  
Email: cgh@cdc.gov  
Web: http://www.cdc.gov/global     
 
  
    
 
For more country information:  http://www.cdc.gov/globalhealth/kenya 
